121 related articles for article (PubMed ID: 25950430)
1. The Effects and Molecular Mechanisms of MiR-106a in Multidrug Resistance Reversal in Human Glioma U87/DDP and U251/G Cell Lines.
Wang Q; Wang Z; Chu L; Li X; Kan P; Xin X; Zhu Y; Yang P
PLoS One; 2015; 10(5):e0125473. PubMed ID: 25950430
[TBL] [Abstract][Full Text] [Related]
2. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-106a confers cisplatin resistance in non-small cell lung cancer A549 cells by targeting adenosine triphosphatase-binding cassette A1.
Ma Y; Li X; Cheng S; Wei W; Li Y
Mol Med Rep; 2015 Jan; 11(1):625-32. PubMed ID: 25339370
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
Feng R; Dong L
Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
[TBL] [Abstract][Full Text] [Related]
5. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
Wang Q; Zhu Y; Yang P
Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
[TBL] [Abstract][Full Text] [Related]
6. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
Cui Y; Yang F; He L
Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mTOR by miR-107 to facilitate glioma cell apoptosis and to enhance cisplatin sensitivity.
Su PF; Song SQ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6864-6872. PubMed ID: 30402851
[TBL] [Abstract][Full Text] [Related]
10. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
Xu P; Jiang YF; Wang JH
Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
[TBL] [Abstract][Full Text] [Related]
11. miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells.
Fang Y; Shen H; Li H; Cao Y; Qin R; Long L; Zhu X; Xie C; Xu W
Acta Biochim Biophys Sin (Shanghai); 2013 Nov; 45(11):963-72. PubMed ID: 24108762
[TBL] [Abstract][Full Text] [Related]
12. Effect of microRNA-128 on cisplatin resistance of glioma SHG-44 cells by targeting JAG1.
Yi DY; Su Q; Zhang FC; Fu P; Zhang Q; Cen YC; Zhao HY; Xiang W
J Cell Biochem; 2018 Apr; 119(4):3162-3173. PubMed ID: 29091297
[TBL] [Abstract][Full Text] [Related]
13. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3.
Zhang Y; Lu Q; Cai X
FEBS Lett; 2013 Sep; 587(18):3069-75. PubMed ID: 23932924
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway.
Qian C; Li P; Yan W; Shi L; Zhang J; Wang Y; Liu H; You Y
Mol Med Rep; 2015 Mar; 11(3):1951-5. PubMed ID: 25405848
[TBL] [Abstract][Full Text] [Related]
16. Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line.
Zhang K; Wang X; Wang H
Mol Med Rep; 2014 Oct; 10(4):2065-72. PubMed ID: 25109654
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of IL-7 enhances cisplatin resistance in glioma.
Cui L; Fu J; Pang JC; Qiu ZK; Liu XM; Chen FR; Shi HL; Ng HK; Chen ZP
Cancer Biol Ther; 2012 May; 13(7):496-503. PubMed ID: 22415136
[TBL] [Abstract][Full Text] [Related]
18. MiR-205 enhances cisplatin sensitivity of glioma cells by targeting E2F1.
Li FF; Xing C; Wu LL; Xue F
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):299-306. PubMed ID: 29424887
[TBL] [Abstract][Full Text] [Related]
19. Gli1 is a potential target for alleviating multidrug resistance of gliomas.
Cui D; Xu Q; Wang K; Che X
J Neurol Sci; 2010 Jan; 288(1-2):156-66. PubMed ID: 19818966
[TBL] [Abstract][Full Text] [Related]
20. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines].
Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]